{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-085646","form_type":"8-K","ticker":"ITRMF","cik":"0001659323","company_name":"Iterum Therapeutics plc","filed_at":"2026-03-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.790622+00:00","generated_at":"2026-05-15T22:40:41.066991+00:00","sec_items":["3.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.95,"confidence":"high","headline":"Iterum Therapeutics receives Nasdaq delisting notice; shares to suspend Mar 5, 2026","bullets":["Received delisting determination letter on Feb 24, 2026 for failing minimum bid price of $1.00 per share.","Trading suspension on Nasdaq effective March 5, 2026 unless hearing requested before Nasdaq Hearings Panel.","Company evaluating appeal and strategic alternatives including possible wind-down or bankruptcy.","Also noncompliant with $35M minimum market value of listed securities and other listing standards.","Warns shareholders are unlikely to receive any meaningful distribution in a potential dissolution."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-085646","json":"https://secwatch.observer/filing/0001193125-26-085646.json","markdown":"https://secwatch.observer/filing/0001193125-26-085646.md","text":"https://secwatch.observer/filing/0001193125-26-085646.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1659323/000119312526085646/0001193125-26-085646-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1659323/000119312526085646/itrm-20260224.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T22:40:41.066991+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}